{"comparisonGroups":["Control","nsPEF_7_day"],"dateCreated":"2025-09-26 00:00:00","display_title":"nsPEF treatment vs control (7 days)","group_a_title":"Control group with no treatment. Serves as the reference point for all treatment comparisons","group_b_title":"Samples treated with nsPEF for 7 days. Represents long-term response to nsPEF treatment","id":"MTBLS2406_0001_00000009","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":739,"studyId":"MTBLS2406","studyUrl":"http://integmet.org/study/MTBLS2406","title":"Control_vs_nsPEF_7_day","topHits":[{"chebi_id":"168327","direction":"down","inn_name":"","iupac_name":"(2S)-2-hydrazinyl-3-(4-hydroxy-3-methoxyphenyl)-2-methylpropanoic acid","metabolite_id":"CZEXQBQCMOVXGP-NSHDSACASA-N","pvalue":3.6455296591107875e-11,"ratio":1.3597720571537052e-10,"synonym_name":""},{"chebi_id":"175165","direction":"down","inn_name":"","iupac_name":"8,17-dihydroxy-6,19-dimethoxy-14,14-dimethyl-3,15-dioxapentacyclo[11.6.1.02,11.04,9.016,20]icosa-1(19),2(11),4,6,8,16(20),17-heptaen-10-one","metabolite_id":"LDQNIBPJKBVZEF-UHFFFAOYSA-N","pvalue":3.343576412077613e-12,"ratio":1.068671146306566e-09,"synonym_name":""},{"chebi_id":"167953","direction":"down","inn_name":"","iupac_name":"2-[4,5-dihydroxy-6-(hydroxymethyl)piperidin-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol","metabolite_id":"CQLSQWAVFSEMIE-UHFFFAOYSA-N","pvalue":2.7447422427969545e-10,"ratio":2.409296897094288e-10,"synonym_name":""},{"chebi_id":"73646","direction":"down","inn_name":"","iupac_name":"<small>L</small>-prolyl-<small>L</small>-proline","metabolite_id":"RWCOTTLHDJWHRS-YUMQZZPRSA-N","pvalue":1.956466595160193e-09,"ratio":2.2179927046137e-10,"synonym_name":"P-P"},{"chebi_id":"168958","direction":"down","inn_name":"","iupac_name":"6-[6-[(2-carboxyacetyl)oxymethyl]-2,4,5-trihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid","metabolite_id":"NOLPUILTGZBYGW-UHFFFAOYSA-N","pvalue":5.557439396165735e-10,"ratio":2.439957053411744e-09,"synonym_name":""},{"chebi_id":"8674","direction":"down","inn_name":"","iupac_name":"4,6-dimethyl-<em>N</em>-phenylpyrimidin-2-amine","metabolite_id":"ZLIBICFPKPWGIZ-UHFFFAOYSA-N","pvalue":1.6176093378785748e-08,"ratio":1.3132216748755047e-10,"synonym_name":"4,6-Dimethyl-N-phenyl-2-pyrimidinamine"},{"chebi_id":"173621","direction":"down","inn_name":"","iupac_name":"1-(2-amino-3-hydroxybutanoyl)pyrrolidine-2-carboxylic acid","metabolite_id":"QOLYAJSZHIJCTO-UHFFFAOYSA-N","pvalue":3.2260929283082395e-08,"ratio":1.6823241909026099e-09,"synonym_name":""},{"chebi_id":"36791","direction":"down","inn_name":"escitalopram","iupac_name":"(1<i>S</i>)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile","metabolite_id":"WSEQXVZVJXJVFP-FQEVSTJZSA-N","pvalue":5.816087911522803e-07,"ratio":2.2664320394124703e-10,"synonym_name":"<i>S</i>(+)-citalopram"},{"chebi_id":"168143","direction":"down","inn_name":"","iupac_name":"2-[2-[(E)-pent-2-enyl]-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclopentyl]acetic acid","metabolite_id":"GJZJZRWFRZFTEE-ONEGZZNKSA-N","pvalue":8.450745944824998e-07,"ratio":1.7409886010655998e-10,"synonym_name":""},{"chebi_id":"16353","direction":"down","inn_name":"","iupac_name":"2-[(2<i>E</i>)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyloxy]-<em>N</em>,<em>N</em>,<em>N</em>-trimethylethanaminium","metabolite_id":"HUJXHFRXWWGYQH-UHFFFAOYSA-O","pvalue":3.5813788579449127e-06,"ratio":2.1590187438228136e-09,"synonym_name":"Sinapoylcholine"}],"totalFeatures":2383}